Table 3.
Vancomycin MIC Distributions of S. aureus Isolates Collected From Participating SENTRY Program Centers, 1997–2016
| No. (Cumulative %) at Each Vancomycin MIC, mg/L | ||||||||
|---|---|---|---|---|---|---|---|---|
| No. | ≤0.12 | 0.25 | 0.5 | 1 | 2 | 4 | 8 | |
| MSSA | 114 297 | 49 (0.1) | 243 (0.4) | 28 862 (25.5) | 83 549 (98.6) | 1569 (>99.9) | 25 (100.0) | |
| MRSA | 77 145 | 18 (<0.1) | 220 (0.3) | 15 807 (20.8) | 57 319 (95.1) | 3745 (>99.9) | 35 (>99.9) | 1 (100.0) |
| Total | 191 442 | 67 (<0.1) | 463 (0.3) | 44 669 (23.6) | 140 868 (97.2) | 5314 (>99.9) | 60 (>99.9) | 1 (100.0) |
Abbreviations: MIC, minimum inhibitory concentration; MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-susceptible S. aureus.